BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
By LabMedica International staff writers Posted on 06 Aug 2019 |

Image: The Novarum mobile app enables rapid POCT using just a smartphone (Photo courtesy of BBI Solutions).
BBI Solutions (Crumlin, UK) demonstrated how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine trade show, American Association for Clinical Chemistry (AACC) exhibition.
BBI Solutions are leading experts in immunoassay development & manufacturing services, offering an extensive portfolio of diagnostic products globally. At the AACC Clinical Lab Expo, BBI’s mobile arm, Novarum, launched a demonstrator app that can read the results of an imitated malaria test. Novarum is an easy-to-use mobile app enabling rapid POCT, using just a smartphone. Novarum’s technology accurately interprets the results of lateral flow assays while offering test choreography and tracking disease outbreaks, providing clients with a competitive advantage within the diagnostic landscape. At the tradeshow, the company demonstrated how mobile technology can remove complexities from lateral flow testing to enable healthcare professionals or patients to deliver lab quality results in the field.
Novarum’s innovative mobile technology mitigates the risks identified around lateral flow by the Clinical Laboratory Improvement Amendments (CLIA), which establishes quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results. The company demonstrated every aspect of its immunoassay development - feasibility and planning, reagent supply and manufacturing, custom antibody development, custom conjugations, lateral flow development and manufacturing, as well as Novarum’s smartphone reader capability which enables immediate, POC diagnosis.
“This is an exciting opportunity to, once again, showcase BBI Solutions’ comprehensive suite of capabilities at the AACC expo. We’re particularly excited to be launching our demo app at the event this year, which enables us to demonstrate every aspect of Novarum’s capability that a potential customer could include in a custom-built app,” said John Hanson, Chief Commercial Officer at BBI Solutions. “We want to help our customers envision what it would be like for the healthcare professional or patient using the test and to highlight how Novarum’s software mitigates the risks identified around lateral flow testing.”
BBI Solutions are leading experts in immunoassay development & manufacturing services, offering an extensive portfolio of diagnostic products globally. At the AACC Clinical Lab Expo, BBI’s mobile arm, Novarum, launched a demonstrator app that can read the results of an imitated malaria test. Novarum is an easy-to-use mobile app enabling rapid POCT, using just a smartphone. Novarum’s technology accurately interprets the results of lateral flow assays while offering test choreography and tracking disease outbreaks, providing clients with a competitive advantage within the diagnostic landscape. At the tradeshow, the company demonstrated how mobile technology can remove complexities from lateral flow testing to enable healthcare professionals or patients to deliver lab quality results in the field.
Novarum’s innovative mobile technology mitigates the risks identified around lateral flow by the Clinical Laboratory Improvement Amendments (CLIA), which establishes quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results. The company demonstrated every aspect of its immunoassay development - feasibility and planning, reagent supply and manufacturing, custom antibody development, custom conjugations, lateral flow development and manufacturing, as well as Novarum’s smartphone reader capability which enables immediate, POC diagnosis.
“This is an exciting opportunity to, once again, showcase BBI Solutions’ comprehensive suite of capabilities at the AACC expo. We’re particularly excited to be launching our demo app at the event this year, which enables us to demonstrate every aspect of Novarum’s capability that a potential customer could include in a custom-built app,” said John Hanson, Chief Commercial Officer at BBI Solutions. “We want to help our customers envision what it would be like for the healthcare professional or patient using the test and to highlight how Novarum’s software mitigates the risks identified around lateral flow testing.”
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- Sysmex America Exhibits New Products, Automation and Quality Solutions
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine
- Orion Diagnostica Showcases Range of Products in Anaheim
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more